Suchergebnisse - "Cost"

Cost savings from prioritization of non-invasive modalities within CAD diagnostic protocols: a systematic review.

Autoren: Kluge B Harris J Sánchez-Collado I et al.

Quelle: Journal of medical economics [J Med Econ] 2025 Dec; Vol. 28 (1), pp. 1388-1404. Date of Electronic Publication: 2025 Sep 01.

Publikationsart: Journal Article; Systematic Review; Review

Info zur Zeitschrift: Publisher: Taylor & Francis Country of Publication: England NLM ID: 9892255 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1941-837X (Electronic) Linking ISSN: 13696998 NLM ISO Abbreviation: J Med Econ Subsets: MEDLINE

MeSH-Schlagworte: Coronary Artery Disease*/diagnosis , Coronary Artery Disease*/diagnostic imaging , Coronary Artery Disease*/economics , Cost Savings*, Humans ; Coronary Angiography/economics ; Coronary Angiography/methods ; Fractional Flow Reserve, Myocardial ; Myocardial Perfusion Imaging/economics ; Computed Tomography Angiography/economics ; Cost-Benefit Analysis

Cost analysis and cost-effectiveness of traditional Chinese medicine in lung cancer: a scoping review.

Autoren: An R Su G

Quelle: Frontiers in public health [Front Public Health] 2025 Nov 03; Vol. 13, pp. 1669751. Date of Electronic Publication: 2025 Nov 03 (Print Publication: 2025).

Publikationsart: Journal Article; Scoping Review; Review

Info zur Zeitschrift: Publisher: Frontiers Editorial Office Country of Publication: Switzerland NLM ID: 101616579 Publication Model: eCollection Cited Medium: Internet ISSN: 2296-2565 (Electronic) Linking ISSN: 22962565 NLM ISO Abbreviation: Front Public Health Subsets: MEDLINE

MeSH-Schlagworte: Lung Neoplasms*/therapy , Lung Neoplasms*/economics , Lung Neoplasms*/drug therapy , Medicine, Chinese Traditional*/economics , Cost-Benefit Analysis* , Carcinoma, Non-Small-Cell Lung*/therapy, Humans ; Quality-Adjusted Life Years ; Costs and Cost Analysis ; China

Cost-Effectiveness Analysis Comparing Ceftazidime/Avibactam With Standard of Care in the Treatment of Hospital and Ventilator-Acquired Pneumonia in the Philippines.

Autoren: Solante RM Tiu D Tan K et al.

Quelle: Value in health regional issues [Value Health Reg Issues] 2025 Nov; Vol. 50, pp. 101158. Date of Electronic Publication: 2025 Aug 07.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: Elsevier Country of Publication: United States NLM ID: 101592642 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2212-1102 (Electronic) Linking ISSN: 22121099 NLM ISO Abbreviation: Value Health Reg Issues Subsets: MEDLINE

MeSH-Schlagworte: Ceftazidime*/therapeutic use , Ceftazidime*/economics , Cost-Benefit Analysis*/statistics & numerical data , Cost-Benefit Analysis*/methods , Anti-Bacterial Agents*/therapeutic use , Anti-Bacterial Agents*/economics , Pneumonia, Ventilator-Associated*/drug therapy , Pneumonia, Ventilator-Associated*/economics , Azabicyclo Compounds*/therapeutic use , Azabicyclo Compounds*/economics , Standard of Care*/economics , Standard of Care*/standards , Standard of Care*/statistics & numerical data , Healthcare-Associated Pneumonia*/drug therapy, Humans ; Philippines ; Drug Combinations ; Female ; Male ; Middle Aged ; Meropenem/therapeutic use ; Cost-Effectiveness Analysis

Overview of Challenges With Using Cost-Effectiveness Analysis for Evaluating Medications.

Autoren: Edwards CJ Erstad BL

Quelle: The Annals of pharmacotherapy [Ann Pharmacother] 2025 Nov; Vol. 59 (11), pp. 1037-1042. Date of Electronic Publication: 2025 Apr 23.

Publikationsart: Journal Article; Review

Info zur Zeitschrift: Publisher: Sage Country of Publication: United States NLM ID: 9203131 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1542-6270 (Electronic) Linking ISSN: 10600280 NLM ISO Abbreviation: Ann Pharmacother Subsets: MEDLINE

MeSH-Schlagworte: Cost-Benefit Analysis*/methods , Prescription Drugs*/economics, Humans ; United States ; Quality-Adjusted Life Years ; Australia ; Cost-Effectiveness Analysis

Cost-effectiveness analysis of metagenomic next-generation sequencing versus traditional bacterial cultures for postoperative central nervous system infections in critical care settings: a prospective pilot study.

Autoren: Tian Y Xu N Chen Y et al.

Quelle: Frontiers in cellular and infection microbiology [Front Cell Infect Microbiol] 2025 Oct 28; Vol. 15, pp. 1710412. Date of Electronic Publication: 2025 Oct 28 (Print Publication: 2025).

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: Frontiers Media SA Country of Publication: Switzerland NLM ID: 101585359 Publication Model: eCollection Cited Medium: Internet ISSN: 2235-2988 (Electronic) Linking ISSN: 22352988 NLM ISO Abbreviation: Front Cell Infect Microbiol Subsets: MEDLINE

MeSH-Schlagworte: Cost-Benefit Analysis* , High-Throughput Nucleotide Sequencing*/economics , High-Throughput Nucleotide Sequencing*/methods , Central Nervous System Infections*/diagnosis , Central Nervous System Infections*/microbiology , Central Nervous System Infections*/economics , Metagenomics*/economics , Metagenomics*/methods , Critical Care*/economics , Bacteria*/genetics , Bacteria*/isolation & purification , Bacteria*/classification , Postoperative Complications*/microbiology , Postoperative Complications*/diagnosis , Bacteriological Techniques*/economics , Bacteriological Techniques*/methods, Humans ; Pilot Projects ; Prospective Studies ; Female ; Male ; Middle Aged ; Aged ; Adult ; Intensive Care Units ; China ; Cost-Effectiveness Analysis

Cost-effectiveness analysis of anlotinib plus penpulimab versus sorafenib in the treatment of unresectable hepatocellular carcinoma.

Autoren: Luo J Li Z Gui C et al.

Quelle: Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2025 Dec; Vol. 21 (1), pp. 2582294. Date of Electronic Publication: 2025 Dec 01.

Publikationsart: Journal Article; Comparative Study

Info zur Zeitschrift: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101572652 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2164-554X (Electronic) Linking ISSN: 21645515 NLM ISO Abbreviation: Hum Vaccin Immunother Subsets: MEDLINE

MeSH-Schlagworte: Carcinoma, Hepatocellular*/drug therapy , Carcinoma, Hepatocellular*/economics , Cost-Benefit Analysis* , Sorafenib*/economics , Sorafenib*/therapeutic use , Sorafenib*/administration & dosage , Liver Neoplasms*/drug therapy , Liver Neoplasms*/economics , Quinolines*/economics , Quinolines*/therapeutic use , Quinolines*/administration & dosage , Indoles*/economics , Indoles*/therapeutic use , Indoles*/administration & dosage , Antineoplastic Agents*/economics , Antineoplastic Agents*/therapeutic use , Antineoplastic Combined Chemotherapy Protocols*/economics , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use, Humans ; Quality-Adjusted Life Years ; China ; Male ; Cost-Effectiveness Analysis ; Antibodies, Monoclonal, Humanized

Comparing pulsed field ablation and thermal energy catheter ablation for paroxysmal atrial fibrillation: a cost-effectiveness analysis of the ADVENT trial.

Autoren: Padula WV Paffrath A Jacobsen CM et al.

Quelle: Journal of medical economics [J Med Econ] 2025 Dec; Vol. 28 (1), pp. 127-135. Date of Electronic Publication: 2025 Jan 02.

Publikationsart: Journal Article; Randomized Controlled Trial; Comparative Study

Info zur Zeitschrift: Publisher: Taylor & Francis Country of Publication: England NLM ID: 9892255 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1941-837X (Electronic) Linking ISSN: 13696998 NLM ISO Abbreviation: J Med Econ Subsets: MEDLINE

MeSH-Schlagworte: Atrial Fibrillation*/surgery , Atrial Fibrillation*/economics , Cost-Benefit Analysis* , Quality-Adjusted Life Years* , Catheter Ablation*/economics , Catheter Ablation*/methods , Markov Chains*, Humans ; Decision Trees ; Female ; Male ; Models, Econometric ; Health Expenditures/statistics & numerical data ; United States ; Middle Aged ; Cost-Effectiveness Analysis

Cost-effectiveness analysis of nirsevimab for prevention of respiratory syncytial virus disease among infants in Shanghai, China: A modeling study.

Autoren: Wang Q Wu J Li L et al.

Quelle: Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2025 Dec; Vol. 21 (1), pp. 2506288. Date of Electronic Publication: 2025 May 20.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101572652 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2164-554X (Electronic) Linking ISSN: 21645515 NLM ISO Abbreviation: Hum Vaccin Immunother Subsets: MEDLINE

MeSH-Schlagworte: Respiratory Syncytial Virus Infections*/prevention & control , Respiratory Syncytial Virus Infections*/economics , Respiratory Syncytial Virus Infections*/epidemiology , Cost-Benefit Analysis* , Antibodies, Monoclonal, Humanized*/economics , Antibodies, Monoclonal, Humanized*/administration & dosage , Antibodies, Monoclonal, Humanized*/therapeutic use , Antiviral Agents*/economics , Antiviral Agents*/administration & dosage , Antiviral Agents*/therapeutic use, Humans ; China/epidemiology ; Infant ; Markov Chains ; Quality-Adjusted Life Years ; Female ; Infant, Newborn ; Male ; Cost-Effectiveness Analysis

A cost-effectiveness analysis of adult human papillomavirus vaccination strategies in Italy.

Autoren: Cherif A Palmer C Senese F et al.

Quelle: Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2025 Dec; Vol. 21 (1), pp. 2474891. Date of Electronic Publication: 2025 Mar 17.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101572652 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2164-554X (Electronic) Linking ISSN: 21645515 NLM ISO Abbreviation: Hum Vaccin Immunother Subsets: MEDLINE

MeSH-Schlagworte: Cost-Benefit Analysis* , Papillomavirus Vaccines*/economics , Papillomavirus Vaccines*/administration & dosage , Papillomavirus Vaccines*/immunology , Papillomavirus Infections*/prevention & control , Papillomavirus Infections*/epidemiology , Papillomavirus Infections*/economics , Vaccination*/economics , Vaccination*/methods, Humans ; Italy/epidemiology ; Female ; Male ; Adolescent ; Adult ; Young Adult ; Child ; Uterine Cervical Neoplasms/prevention & control ; Uterine Cervical Neoplasms/epidemiology ; Immunization Programs/economics ; Middle Aged ; Incidence ; Cost-Effectiveness Analysis ; Human Papillomavirus Viruses

Cost-effectiveness analysis of radiofrequency renal denervation for uncontrolled hypertension in Canada.

Autoren: McFarlane PA Madan M Ryschon AM et al.

Quelle: Journal of medical economics [J Med Econ] 2025 Dec; Vol. 28 (1), pp. 70-80. Date of Electronic Publication: 2024 Dec 19.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: Taylor & Francis Country of Publication: England NLM ID: 9892255 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1941-837X (Electronic) Linking ISSN: 13696998 NLM ISO Abbreviation: J Med Econ Subsets: MEDLINE

MeSH-Schlagworte: Cost-Benefit Analysis* , Hypertension*/surgery , Quality-Adjusted Life Years* , Markov Chains*, Humans ; Canada ; Male ; Female ; Kidney/innervation ; Middle Aged ; Stroke/economics ; Stroke/complications ; Catheter Ablation/methods ; Catheter Ablation/economics ; Myocardial Infarction ; Denervation/methods ; Denervation/economics ; Cost-Effectiveness Analysis

Comparative cost-effectiveness analysis between navigated robot-assisted platforms and O-arm navigation in minimally invasive transforaminal interbody fusion (MIS-TLIF).

Autoren: Wan JJY Yeo J Chew Z et al.

Quelle: The spine journal : official journal of the North American Spine Society [Spine J] 2025 Dec; Vol. 25 (12), pp. 2686-2691. Date of Electronic Publication: 2025 May 09.

Publikationsart: Journal Article; Comparative Study

Info zur Zeitschrift: Publisher: Elsevier Science Inc Country of Publication: United States NLM ID: 101130732 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-1632 (Electronic) Linking ISSN: 15299430 NLM ISO Abbreviation: Spine J Subsets: MEDLINE

MeSH-Schlagworte: Spinal Fusion*/economics , Spinal Fusion*/methods , Cost-Benefit Analysis* , Minimally Invasive Surgical Procedures*/economics , Minimally Invasive Surgical Procedures*/methods , Robotic Surgical Procedures*/economics , Robotic Surgical Procedures*/methods , Lumbar Vertebrae*/surgery, Humans ; Female ; Male ; Middle Aged ; Retrospective Studies ; Aged ; Length of Stay/economics ; Postoperative Complications/economics ; Operative Time ; Treatment Outcome ; Cost-Effectiveness Analysis

Eye injury rates and community cost savings through vision centers: Evidence from southern India.

Autoren: Rajendran VK Gowth AM Balasubramanian A et al.

Quelle: Indian journal of ophthalmology [Indian J Ophthalmol] 2025 Dec 01; Vol. 73 (12), pp. 1807-1812. Date of Electronic Publication: 2025 Sep 19.

Publikationsart: Journal Article; Multicenter Study

Info zur Zeitschrift: Publisher: Medknow Publications Country of Publication: India NLM ID: 0405376 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1998-3689 (Electronic) Linking ISSN: 03014738 NLM ISO Abbreviation: Indian J Ophthalmol Subsets: MEDLINE

MeSH-Schlagworte: Eye Injuries*/epidemiology , Eye Injuries*/economics , Cost Savings*, Humans ; India/epidemiology ; Retrospective Studies ; Male ; Adult ; Female ; Middle Aged ; Young Adult ; Incidence ; Adolescent ; Child ; Cost-Benefit Analysis ; Child, Preschool ; Aged

A benefit-cost analysis quantifying the broader socioeconomic value of adult respiratory vaccination programs in Japan.

Autoren: Theakston C Napier M Brassel S et al.

Quelle: Expert review of vaccines [Expert Rev Vaccines] 2025 Dec; Vol. 24 (1), pp. 633-643. Date of Electronic Publication: 2025 Jul 22.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101155475 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8395 (Electronic) Linking ISSN: 14760584 NLM ISO Abbreviation: Expert Rev Vaccines Subsets: MEDLINE

MeSH-Schlagworte: Immunization Programs*/economics , COVID-19*/prevention & control , COVID-19*/economics , COVID-19*/epidemiology , Cost-Benefit Analysis* , Vaccination*/economics , COVID-19 Vaccines*/economics , COVID-19 Vaccines*/administration & dosage , Respiratory Tract Infections*/prevention & control , Respiratory Tract Infections*/economics , Respiratory Tract Infections*/epidemiology, Humans ; Japan/epidemiology ; Adult ; Aged ; Middle Aged ; Cost of Illness ; Socioeconomic Factors ; Male

Cost effectiveness analysis of six non insulin agents for type 2 diabetes in Iran using a patient level simulation with UKPDS OM2.

Autoren: Darvishi A Daroudi R Dehghan S et al.

Quelle: Scientific reports [Sci Rep] 2025 Nov 24; Vol. 15 (1), pp. 41536. Date of Electronic Publication: 2025 Nov 24.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

MeSH-Schlagworte: Diabetes Mellitus, Type 2*/drug therapy , Diabetes Mellitus, Type 2*/economics , Diabetes Mellitus, Type 2*/epidemiology , Cost-Benefit Analysis* , Hypoglycemic Agents*/therapeutic use , Hypoglycemic Agents*/economics, Humans ; Iran/epidemiology ; Female ; Male ; Middle Aged ; Quality-Adjusted Life Years ; Pioglitazone/therapeutic use ; Pioglitazone/economics ; Metformin/therapeutic use ; Metformin/economics ; Aged ; Adult ; Benzhydryl Compounds/therapeutic use ; Benzhydryl Compounds/economics ; Computer Simulation ; Liraglutide/therapeutic use ; Liraglutide/economics ; Glucosides/therapeutic use ; Glucosides/economics ; Cost-Effectiveness Analysis

Use of Large Language Models to Extract Cost-Effectiveness Analysis Data: A Case Study.

Autoren: Gu X Zhang H Patil D et al.

Quelle: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2025 Nov; Vol. 28 (11), pp. 1637-1645. Date of Electronic Publication: 2025 Jun 04.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: Elsevier Country of Publication: United States NLM ID: 100883818 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1524-4733 (Electronic) Linking ISSN: 10983015 NLM ISO Abbreviation: Value Health Subsets: MEDLINE

MeSH-Schlagworte: Cost-Benefit Analysis*/methods , Artificial Intelligence* , Data Collection*/methods , Language*, Humans ; Cost-Effectiveness Analysis ; Large Language Models

Updated cost-effectiveness analysis of first-line novel therapies in locally advanced or metastatic urothelial carcinoma across the UK, US, and China.

Autoren: Lin J Fu W You C et al.

Quelle: World journal of urology [World J Urol] 2025 Oct 31; Vol. 43 (1), pp. 657. Date of Electronic Publication: 2025 Oct 31.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: Springer International Country of Publication: Germany NLM ID: 8307716 Publication Model: Electronic Cited Medium: Internet ISSN: 1433-8726 (Electronic) Linking ISSN: 07244983 NLM ISO Abbreviation: World J Urol Subsets: MEDLINE

MeSH-Schlagworte: Cost-Benefit Analysis* , Carcinoma, Transitional Cell*/drug therapy , Carcinoma, Transitional Cell*/economics , Carcinoma, Transitional Cell*/secondary , Carcinoma, Transitional Cell*/pathology , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Antineoplastic Combined Chemotherapy Protocols*/economics , Urinary Bladder Neoplasms*/drug therapy , Urinary Bladder Neoplasms*/pathology , Urinary Bladder Neoplasms*/economics , Urologic Neoplasms*/drug therapy , Urologic Neoplasms*/pathology , Urologic Neoplasms*/economics, Humans ; United Kingdom ; China ; United States ; Cisplatin/economics ; Cisplatin/therapeutic use ; Deoxycytidine/analogs & derivatives ; Deoxycytidine/economics ; Deoxycytidine/administration & dosage ; Antibodies, Monoclonal, Humanized/economics ; Antibodies, Monoclonal, Humanized/therapeutic use ; Neoplasm Metastasis ; Gemcitabine ; Quality-Adjusted Life Years ; Markov Chains ; Cost-Effectiveness Analysis

International cost-effectiveness analysis in osimertinib after chemoradiotherapy in stage III EGFR-mutated non-small cell lung cancer.

Autoren: Tang D Zou X Wei C et al.

Quelle: Frontiers in public health [Front Public Health] 2025 Oct 29; Vol. 13, pp. 1698562. Date of Electronic Publication: 2025 Oct 29 (Print Publication: 2025).

Publikationsart: Clinical Trial, Phase III; Journal Article

Info zur Zeitschrift: Publisher: Frontiers Editorial Office Country of Publication: Switzerland NLM ID: 101616579 Publication Model: eCollection Cited Medium: Internet ISSN: 2296-2565 (Electronic) Linking ISSN: 22962565 NLM ISO Abbreviation: Front Public Health Subsets: MEDLINE

MeSH-Schlagworte: Acrylamides*/therapeutic use , Acrylamides*/economics , Aniline Compounds*/therapeutic use , Aniline Compounds*/economics , Antineoplastic Agents*/economics , Antineoplastic Agents*/therapeutic use , Carcinoma, Non-Small-Cell Lung*/drug therapy , Carcinoma, Non-Small-Cell Lung*/genetics , Carcinoma, Non-Small-Cell Lung*/therapy , Chemoradiotherapy* , Cost-Benefit Analysis* , Lung Neoplasms*/drug therapy , Lung Neoplasms*/therapy , Lung Neoplasms*/genetics, Female ; Humans ; Male ; Middle Aged ; China ; Cost-Effectiveness Analysis ; ErbB Receptors/genetics ; Mutation ; Neoplasm Staging ; Quality-Adjusted Life Years ; United States ; Indoles ; Pyrimidines

Cost effectiveness analysis of low dose computed tomography lung cancer screening in Chinese population.

Autoren: Yao Y Jin Y Ji C et al.

Quelle: Scientific reports [Sci Rep] 2025 Oct 27; Vol. 15 (1), pp. 37484. Date of Electronic Publication: 2025 Oct 27.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

MeSH-Schlagworte: Lung Neoplasms*/diagnostic imaging , Lung Neoplasms*/epidemiology , Lung Neoplasms*/economics , Lung Neoplasms*/diagnosis , Cost-Benefit Analysis* , Tomography, X-Ray Computed*/economics , Tomography, X-Ray Computed*/methods , Early Detection of Cancer*/economics , Early Detection of Cancer*/methods, Humans ; Middle Aged ; China/epidemiology ; Aged ; Adult ; Male ; Female ; Markov Chains ; Aged, 80 and over ; Mass Screening/economics ; Mass Screening/methods ; Incidence ; Cost-Effectiveness Analysis

Socioeconomic value of treatments for chronic idiopathic constipation in Japan.

Autoren: Nakajima A Unno A Ota T et al.

Quelle: BMC gastroenterology [BMC Gastroenterol] 2025 Oct 21; Vol. 25 (1), pp. 748. Date of Electronic Publication: 2025 Oct 21.

Publikationsart: Journal Article; Comparative Study

Info zur Zeitschrift: Publisher: BioMed Central Country of Publication: England NLM ID: 100968547 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-230X (Electronic) Linking ISSN: 1471230X NLM ISO Abbreviation: BMC Gastroenterol Subsets: MEDLINE

MeSH-Schlagworte: Constipation*/drug therapy , Constipation*/economics , Peptides*/economics , Peptides*/therapeutic use , Cost of Illness*, Humans ; Quality of Life ; Cost-Benefit Analysis ; Japan ; Lubiprostone/economics ; Lubiprostone/therapeutic use ; Chronic Disease ; Markov Chains ; Male ; Female ; Middle Aged ; Health Care Costs ; Aged ; Chloride Channel Agonists/economics ; Chloride Channel Agonists/therapeutic use ; Socioeconomic Factors ; Dipeptides ; Thiazepines

Cost effectiveness and pricing strategy of first line benmelstobart combination treatment for extensive stage small cell lung cancer in China.

Autoren: Zhao S Kang S

Quelle: Scientific reports [Sci Rep] 2025 Oct 21; Vol. 15 (1), pp. 36736. Date of Electronic Publication: 2025 Oct 21.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

MeSH-Schlagworte: Cost-Benefit Analysis* , Lung Neoplasms*/drug therapy , Lung Neoplasms*/economics , Lung Neoplasms*/pathology , Lung Neoplasms*/mortality , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Antineoplastic Combined Chemotherapy Protocols*/economics , Small Cell Lung Carcinoma*/drug therapy , Small Cell Lung Carcinoma*/economics , Small Cell Lung Carcinoma*/pathology , Small Cell Lung Carcinoma*/mortality, Humans ; China ; Carboplatin/economics ; Carboplatin/administration & dosage ; Carboplatin/therapeutic use ; Quality-Adjusted Life Years ; Quinolines/economics ; Quinolines/administration & dosage ; Quinolines/therapeutic use ; Indoles/economics ; Indoles/administration & dosage ; Indoles/therapeutic use ; Etoposide/economics ; Etoposide/administration & dosage ; Etoposide/therapeutic use ; Female ; Male ; Neoplasm Staging ; Cost-Effectiveness Analysis